National Drug Code (NDC) Database
Synthon Chile Limitada
-
NDC:
85468-076
-
Nonproprietary Name:
Sacubitril and Valsartan
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
97; 103 mg/1; mg/1
-
Substance:
SACUBITRIL SODIUM; VALSARTAN DISODIUM
-
Start Marketing Date:
2026-03-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
T M Thakore Pharmaceutical Laboratories
-
NDC:
82210-010
-
Nonproprietary Name:
Alcohol, Coal Tar
-
Dosage Form:
SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1; 1 kg/kg; kg/kg
-
Substance:
ALCOHOL; COAL TAR
-
Start Marketing Date:
2021-09-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
TAEKYUNG SBC Co., LTD.
-
NDC:
82525-0021
-
Nonproprietary Name:
Titanium dioxide
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
85 kg/100kg
-
Substance:
TITANIUM DIOXIDE
-
Start Marketing Date:
2025-12-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Taicang Xintai Alcohol Co Ltd
-
NDC:
83983-111
-
Nonproprietary Name:
Ethanol
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
100 L/100L
-
Substance:
ALCOHOL
-
Start Marketing Date:
2024-01-17
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Takeda GmbH, Oranienburg
-
NDC:
47234-1148
-
Nonproprietary Name:
dexlansoprazole
-
Dosage Form:
CAPSULE, DELAYED RELEASE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
30 mg/1
-
Substance:
DEXLANSOPRAZOLE
-
Start Marketing Date:
2018-05-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Takeda Ireland Limited
-
NDC:
66332-6003
-
Nonproprietary Name:
Azilsartan medoxomil and CHLORTHALIDONE
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
40; 25 mg/1; mg/1
-
Substance:
AZILSARTAN MEDOXOMIL; CHLORTHALIDONE
-
Start Marketing Date:
2018-01-29
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Takeda Ireland Ltd.
-
NDC:
66332-7003
-
Nonproprietary Name:
alogliptin
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
25 mg/1
-
Substance:
ALOGLIPTIN BENZOATE
-
Start Marketing Date:
2013-01-25
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Takeda Pharmaceutical Co LTD
-
NDC:
11532-7106
-
Nonproprietary Name:
alogliptin/pioglitazone
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
25; 45 mg/1; mg/1
-
Substance:
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
-
Start Marketing Date:
2012-02-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
82525-0020
-
Nonproprietary Name:
zinc oxide
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
0.975 kg/kg
-
Substance:
ZINC OXIDE
-
Start Marketing Date:
2023-08-28
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
47234-7106
-
Nonproprietary Name:
Alogliptin Benzoate and Pioglitazone Hydrochloride
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
25; 45 mg/1; mg/1
-
Substance:
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
-
Start Marketing Date:
2012-02-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.